» Articles » PMID: 20682000

Hematopoietic Stem Cell Lodgment in the Adult Bone Marrow Stem Cell Niche

Overview
Specialty Hematology
Date 2010 Aug 5
PMID 20682000
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of malignant blood disorders, such as leukemia, that can provide a better chance of long-term remission involves myeloablation followed by transplantation of matched donor hematopoietic stem cells (HSCs). For successful engraftment and re-establishment of hematopoiesis to occur in the recipient, the transplanted HSCs must first migrate from the blood circulation to the bone marrow (BM), a process known as homing, then localize and anchor in suitable microenvironments within the BM, a process known as lodgment. After lodgment, the specific fate of the transplanted HSCs is determined through complex, bidirectional interactions with various stromal cell components in the niche. Ultimately, these interactions dictate the clinical outcome of the transplantation. Through the use of transgenic mouse models, considerable evidence has been accumulated in an attempt to unveil the possible underlying mechanisms that govern these processes. Here, we will emphasize the major factors that are involved in the regulation of lodgment of transplanted HSCs. Specifically, we will first introduce early observations on the spatial distribution of hematopoietic progenitors within the BM, then we will discuss the soluble factors, chemokines, cell-cell interactions, and cell-matrix interactions that have been studied and known to influence the site of HSC lodgment within the BM following transplantation.

Citing Articles

A Novel Identified Necroptosis-Related Risk Signature for Prognosis Prediction and Immune Infiltration Indication in Acute Myeloid Leukemia Patients.

Sun Y, Wang R, Xie S, Wang Y, Liu H Genes (Basel). 2022; 13(10).

PMID: 36292722 PMC: 9602382. DOI: 10.3390/genes13101837.


High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression.

Wittwer N, Brumatti G, Marchant C, Sandow J, Pudney M, Dottore M Blood Adv. 2018; 1(15):1067-1079.

PMID: 29296749 PMC: 5728309. DOI: 10.1182/bloodadvances.2016002931.


Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.

Selleri C, Montuori N, Salvati A, Serio B, Pesapane A, Ricci P Oncotarget. 2016; 7(37):60206-60217.

PMID: 27517491 PMC: 5312379. DOI: 10.18632/oncotarget.11115.


The Effect of Bone Marrow Mesenchymal Stem Cells on Vitamin D3 Induced Monocytic Differentiation of U937 Cells.

Molaeipour Z, Shamsasanjan K, Movassaghpour A, Akbarzadehlaleh P, Sabaghi F, Saleh M Adv Pharm Bull. 2016; 6(1):23-29.

PMID: 27123414 PMC: 4845548. DOI: 10.15171/apb.2016.05.


Hyperbaric oxygen, vasculogenic stem cells, and wound healing.

Fosen K, Thom S Antioxid Redox Signal. 2014; 21(11):1634-47.

PMID: 24730726 PMC: 4175035. DOI: 10.1089/ars.2014.5940.